| Lightcalls.com |
|
|
![]() |
Ginkgo leaf extracts have been show...Ginkgo leaf extracts have been shown to have a wide range of biological activities. The in the greatest degree well-known use among Americans is the documented ability of the extracts to improve short-term memory. The best-selling phytomedicine (medicinal plant) onward the European market is derived from the leaves of an ancient tree known at the same time to survive only in China. Sales of this botanical's extracts are in exces of $280 million by year. The tree is ginkgo -- Ginkgo biloba -- a living fossil. Ginkgo is considered the oldest tree species to survive in succession earth, with a history dating back across 200 million years. Ginkgo's survival record is excellent Ginkgo biloba is the barely surviving member of the ginkgo family. Ginkgo species were one time common in North America and Europe While its relatives became extinct in other parts of the world, ginkgo biloba survived in China, where it became known to Europeans in the 18th hundred and subsequently was introduced as an ornamental tree from beginning to end the Western world. Now ginkgo tree are originate in virtually every city in the United States; it was first introduced here in 1784 The belonging to all name "Ginkgo" is a phonetic pronunciation of a Japanese name for the tree The species name "biloba" leaves to the-two distinct lobes, characteristic of the tree's leaves. Ginkgos have survived throughout millions of years because of their genetic tenacity. They are remarkably resistant to disease, plagues and fires. They also are extremely tolerant of air pollution, and are repeatedly planted in urban environments with harsh air pollution and heavy populations where most numerous trees will not survive. The mostly common tree along Manhattan sidewalks, for example, is ginkgo. The tree will earn to be over 100 feet tall. In Japan and China, tree from one side of to the other a thousand years old are build still growing at ancient fanes Its unique fan-shaped leaves with brace lobes make it one of the easiest tree to identify one time you become familiar with the unusual features. Ginkgo's etymons are in ancient Chinese medicine Despite the fact that the tree spring ups in China, the leaves are not united of the famous classical herbal remedys in ancient Chinese medicine. The first mention in Chinese herbals of use of the leaves issues relatively late. Ginkgo leaf was first mentioned in Lan Mao's Dian Nan Ben Cao (Pharmaceutical Natural History of Southern Yunnan), published in 1436 during the Ming dynasty. Lan Mao notes external use to treat skin and head sores as well as freckle Internal use of the leaves was first noted in Liu Wen-Tai's Ben Cao Pin Hui Jing Yao (Essentials of the Pharmacopoeia Ranked According to Nature and Efficacy), an imperial-commissioned work recorded in 1505 Liu Wen Tai notes use of the leaves in the treatment of diarrhea. The leaves of ginkgo are known in Chinese medicine as bai-guo-ye. novel clinical reports in modern China glance at that the leaves lower serum cholesterol horizontals and have some clinical value in easing angina pectoris (brief attacks of chest pain precipitated from deficient oxygenation of the heart muscle). In Traditional Chinese Medicine the germs with fleshy rind removed, are considered more beneficial than are the leaves. The semens are used as an astringent for the lung to stop asthma, enuresis (urinary incontinence), and excessive leucorrhea (a original of vaginal discharge). It is musing to benefit qi (ch'i, vital energy) cough and regulate urinary common occurrence Studies have shown that the known constituents ginkgoic acid and ginnol inhibit certain bacteria and fungal infections. In large doses, the originals are thought to have a certain quantity of toxic effect, perhaps leading to skin disorders or mucous membrane irritation. Ginkgo leaves, although a Chinese herb, have been used abundant more in the West than in their homeland. throughout 300 scientific studies on the chemistry, pharmacology and clinical events of ginkgo leaf have been convoyed by European researchers over the last 20 to 30 years. Unlike greatest in number herbs, ginkgo leaf extracts, rather than uncooked leaf material, are used for clinical purposes The majority of studies onward ginkgo leaf extract have involved a result produced by a German/French consortium, referr to in the scientific literature as EGb761 Ginkgo issues are standardized to include 24 percent bioflavonoids from the leaf Ginkgo performances are standardized to contain 24 percent of the bioflavonoids (see sidebar upon p. 57) which occur in the leaf, as well as ginkgolides and bilobilides, a complicated group of compounds found no other than in the ginkgo tree. Since virtually all research in succession ginkgo has involved high standardized extracts calibrated to specific quantities of chemical composings it is not possible to apply information from studies in succession the standardized extracts to the ginkgo leaf itself. This intricate extract, rather than a single isolated component part is believed to be responsible for ginkgo's biological activity. However, various research assemblages have recently focused on the general intents of the ginkgolides themselves. They have been base to be very selective antagonists of platelet aggregation (clumping) induced from platelet-activating factor (PAF), an inflammatory autocid. Autocids, synthesized in local tissue sites, mediate tissue answer such as pain perception, house coagulation, and smooth muscle contraction. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |